FFPE sample preparation for reliable DNA, RNA and tissue analysis
Why FFPE sample preparation matters
FFPE sample preparation is the controlled process of turning formalin-fixed, paraffin-embedded tissue into material that can be sectioned, stained, extracted or analyzed by molecular methods. One block may support morphology review, immunohistochemistry, PCR, next-generation sequencing or RNA profiling, but only when the pre-analytical history and extraction workflow fit the intended assay.
Formalin preserves tissue architecture, while also creating crosslinks, chemical modifications and fragmentation that can make nucleic acid recovery difficult. Paraffin protects and supports the tissue, but it has to be removed completely before efficient lysis. For laboratories and researchers, the practical objective is not simply to recover DNA or RNA. The objective is to recover material with enough quantity, purity and amplifiable fragment length for the downstream method.
This article summarizes a workflow-oriented approach to FFPE sample handling, based on widely cited guidance from organizations and technical references such as the National Cancer Institute, the College of American Pathologists, the National Society for Histotechnology, and sequencing platform documentation. For related workflow topics, see our sample preparation section.
What makes FFPE material different from fresh or frozen tissue
FFPE tissue is valued because it preserves microscopic structure and can often be stored for long periods. Pathology archives worldwide contain FFPE blocks that are difficult or impossible to replace, which makes the format important for retrospective studies, biomarker validation and translational research.
The same preservation chemistry creates the main analytical challenge. Formaldehyde reacts with proteins and nucleic acids, forming crosslinks and chemical adducts. During fixation, processing and storage, DNA and RNA may also become fragmented. As a result, FFPE-derived nucleic acids usually behave differently from nucleic acids extracted from fresh or frozen specimens.
FFPE sample preparation should therefore be planned backward from the assay. A hematoxylin and eosin slide, an immunohistochemistry panel, a short-amplicon PCR assay, a targeted DNA panel and RNA sequencing do not have the same input requirements. A workflow that is acceptable for one endpoint may be unsuitable for another.
Pre-analytical variables that decide sample quality
Many FFPE problems begin before extraction. Once tissue has been fixed, embedded and archived, later preparation steps can improve recovery but cannot fully correct poor handling. The most important variables include ischemia time, fixative type, fixation duration, tissue thickness, processing conditions and storage history.
Fixative and fixation time
Neutral buffered formalin is the standard fixative for many FFPE workflows. The National Cancer Institute’s evidence-based guidance for DNA and RNA extraction from FFPE tissue applies specifically to standard cassette-sized, non-decalcified human tissue fixed in 10% neutral buffered formalin for less than 48 hours before paraffin embedding. That scope is important because decalcification, alternative fixatives and prolonged fixation can change nucleic acid recovery and assay performance.
Pathology biomarker guidance may use a different fixation window because the analytical endpoint is different. For example, practical specimen-handling guidance from the College of American Pathologists and the National Society for Histotechnology lists 10% neutral buffered formalin as the recommended fixative and describes 6 to 72 hours as the recommended fixation time for estrogen receptor, progesterone receptor and HER2 testing in breast tissue. The point is not that one range fits every purpose. Fixation requirements need to be linked to the assay and documented consistently.
Tissue size, penetration and processing
Formalin does not penetrate large tissue pieces instantly. Thick specimens, delayed grossing or inadequate fixative volume can lead to uneven fixation. Underfixed areas may show poor morphology, while overfixed or harshly processed material can be harder to digest and may yield more damaged nucleic acids. Laboratories should define maximum tissue thickness, cassette loading practices and processing schedules in the standard operating procedure rather than leaving these choices to individual habit.
Documentation
Useful FFPE preparation records include collection time, time into fixative, fixative type, fixation duration, processing date, block age, decalcification status, section thickness, number of sections and storage conditions for cut slides or scrolls. These details often explain why two blocks with similar tissue area produce very different DNA or RNA results.
A practical FFPE preparation workflow
A reliable workflow separates tissue assessment, sectioning, paraffin removal, digestion, purification and quality control. The sequence below is a general framework. Exact temperatures, incubation times and reagent volumes should follow validated laboratory procedures and the requirements of the intended assay.
| Step | Purpose | Key control point |
|---|---|---|
| Review block and records | Confirm tissue type, fixation history and assay suitability | Reject or flag blocks with incompatible handling, heavy decalcification or missing critical data |
| Mark the region of interest | Enrich tumor, lesion or target tissue | Use pathology review when cellularity or contamination affects interpretation |
| Section the block | Generate slides, curls or scrolls for analysis | Use clean blades, minimize cross-contamination and record thickness and section count |
| Remove paraffin | Expose tissue to lysis reagents | Incomplete deparaffinization can reduce digestion and inhibit downstream reactions |
| Digest and reverse modifications | Release DNA, RNA or protein from fixed tissue | Proteinase K digestion and heat-assisted reversal of formalin-induced modifications are common elements in molecular workflows |
| Purify the analyte | Remove inhibitors, salts, proteins and residual solvent | Choose DNA, RNA or combined extraction chemistry based on the assay |
| Perform quality control | Measure amount, purity and functional quality | Use metrics that predict the selected downstream method, not only total mass |
Cross-contamination needs special attention. Microtomes, water baths, forceps and shared work surfaces can transfer small amounts of tissue between blocks. For sensitive PCR or sequencing assays, laboratories often discard facing sections, clean equipment between samples and separate pre-PCR and post-PCR areas.
DNA preparation for PCR and sequencing
DNA extracted from FFPE tissue is often fragmented and chemically modified. The preparation strategy should emphasize complete paraffin removal, adequate digestion, crosslink reversal and accurate quantification. Shorter amplicons usually perform better than long targets because the chance of finding an intact template decreases as fragment length increases.
For sequencing, total DNA concentration alone is not enough. Spectrophotometric readings can overestimate usable FFPE DNA because they may include degraded nucleotides, RNA or contaminants. Fluorescence-based double-stranded DNA assays are generally more informative for input mass, while qPCR-based quality tests can estimate amplifiable template. Illumina documentation for certain enrichment workflows, for example, uses a ΔCq-based FFPE DNA quality assessment and warns that poorer-quality samples increase the risk of library preparation failure or reduced performance. That threshold is platform-specific, so it should not be copied blindly into unrelated assays.
Three practical decisions improve DNA workflows. First, select a protocol validated for FFPE rather than a generic tissue extraction method. Second, match target size to expected fragmentation. Third, treat borderline samples as a risk category. They may still be usable for small targeted assays but unsuitable for broader sequencing or copy-number applications. See also: analytical methods.
RNA preparation and the role of DV200
RNA is typically more vulnerable than DNA in FFPE material, and conventional RNA integrity metrics can be misleading. The RNA Integrity Number, or RIN, is useful for high-quality RNA, but FFPE RNA is often degraded enough that RIN values cluster at the low end. For FFPE RNA-seq and expression workflows, the DV200 metric is often more informative. DV200 represents the percentage of RNA fragments longer than 200 nucleotides.
Technical guidance from sequencing platform providers has described DV200 as a better predictor of FFPE RNA library preparation performance than RIN for certain workflows. Some RNA library preparation methods do not recommend very low DV200 samples, while others can adjust input amount, fragmentation time or PCR cycling. These adjustments are method-specific. A laboratory should therefore report both concentration and fragment distribution, then decide whether the sample fits the library preparation chemistry.
RNA workflows also require strict nuclease control and careful DNA management. If the endpoint is gene expression, residual genomic DNA can distort quantification. DNase treatment may be necessary, but it must be balanced against recovery loss, especially when input material is limited.
Common failure modes and how to reduce them
| Problem | Likely cause | Risk reduction |
|---|---|---|
| Low nucleic acid yield | Small tissue area, incomplete lysis, old sections or inefficient deparaffinization | Increase section number within assay limits, confirm tissue content and validate digestion conditions |
| Poor PCR amplification | Fragmented template, inhibitors or excessive target length | Use shorter amplicons, improve purification and include functional quality testing |
| Variable results between blocks | Different fixation, processing or storage history | Document pre-analytical variables and stratify samples by handling history |
| RNA library failure | Low fragment size distribution or insufficient usable RNA | Assess DV200, use FFPE-compatible RNA methods and avoid workflows designed only for intact RNA |
| Unexpected variant artifacts | Fixation-related damage, low input or over-amplification | Use validated molecular workflows, controls and bioinformatic filters suited to FFPE data |
The most useful operational habit is to define acceptance criteria before samples arrive. If the project requires RNA-seq, the submission form should ask for block age, sectioning date, tissue area and prior fixation information. If the endpoint is targeted DNA testing, the protocol should define minimum input, acceptable quality metrics and the action to take when a sample fails QC.
Building an SOP for FFPE sample preparation
A strong SOP should be specific enough to reduce variability but flexible enough to account for assay differences. It should define specimen eligibility, section thickness, number of sections, contamination control, deparaffinization method, digestion conditions, purification chemistry, elution volume, storage conditions and QC thresholds.
Validation is essential. The National Cancer Institute’s FFPE nucleic acid extraction guidance emphasizes that procedures should be validated for the anticipated analytical platform. This is a practical requirement, not a formality. A protocol that works for PCR on a short target may not generate material suitable for whole-exome sequencing or transcriptome profiling.
The SOP should also distinguish required data from optional notes. Required fields might include block identifier, section count, thickness, extraction date, operator, yield, purity and fragment-size metric. Optional notes might include unusual tissue hardness, visible paraffin carryover or limited material. Over time, this documentation helps laboratories identify recurring failure patterns and improve acceptance criteria.
Frequently asked questions
Can old FFPE blocks still be used for molecular analysis?
Yes, but performance depends on fixation history, block storage, tissue type and the assay. Older blocks may still work for short PCR targets or targeted panels, while more demanding applications may fail if DNA or RNA is too fragmented. Quality control should be performed before committing valuable material to library preparation.
Is FFPE DNA concentration enough to predict sequencing success?
No. Concentration measures the amount of recovered material, not whether the DNA is amplifiable or sufficiently intact. Fluorescence-based quantification, fragment assessment and qPCR-based quality checks are more useful for many FFPE sequencing workflows.
Why is DV200 used for FFPE RNA?
DV200 estimates the percentage of RNA fragments longer than 200 nucleotides. Because FFPE RNA is usually degraded, DV200 can better reflect whether enough usable RNA fragments remain for certain RNA library preparation methods.
Should every FFPE workflow use the same fixation time?
No. Fixation recommendations vary by tissue type and analytical endpoint. Biomarker immunohistochemistry, DNA extraction and RNA analysis may have different acceptable ranges. The safest approach is to follow validated assay-specific guidance and record fixation details for every specimen.
What is the main takeaway for FFPE sample preparation?
FFPE preparation is an end-to-end quality system. Good results depend on controlled fixation, careful sectioning, complete paraffin removal, validated extraction, assay-specific QC and clear documentation. No single extraction kit can fully compensate for poorly handled tissue.
